| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | Software (Web Marketplace Saas..) • PropTech • IT (& TMT) • Media • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Developer tools • Food & Beverage • Insurance (& InsurTech) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Healthcare (& Wellness) • Investment Management • Consumer • Pharmaceutical (& Medicine) • Woman Focused |
| Stages | Pre-Seed, Seed, Series A |
| Investing | United States • United Kingdom • Germany • France • Israel • Europe |
| Investment Range | $50,000 - $2,000,000 |
| Investment Sweet Spot | $500,000 |
Tectonic Capital is a venture capital firm headquartered in the United States, focusing on seeding and developing early-stage startups across a wide array of industries.
They specialize in investing in Pre-Seed, Seed, and Series A funding rounds with an investment range of $50,000 to $2,000,000, and a sweet spot of approximately $500,000 for investments. The geographic focus remains in the USA, aligning with their headquarters' location.
Tectonic Capital is interested in a diverse portfolio encompassing sectors such as Software, PropTech, IT & TMT, Media, BioTech, AgroTech, Business Solutions, FinTech & Financial Services, Hardware & Manufacturing, Retail & E-commerce, CleanTech, A.I. & Big Data, HealthTech & Fitness, Web Security & Privacy, Developer Tools, Food & Beverage, Insurance & InsurTech, Logistics & Distribution, Medical Devices & Hospital Services, Real Estate & Construction, Healthcare & Wellness, Investment Management, Consumer, Pharmaceutical & Medicine, and Women-focused ventures.
Highlighting their most preferred areas, Tectonic Capital exhibits a particular interest in cutting-edge fields such as CRISPR, synthetic biology, and genomics, stretching across various applications including therapeutics, research tools, companion animals, agtech, biosensors, materials, and fashion.
Conversely, they express a lack of interest in small-molecule therapeutics and companies unrelated to biotech or life sciences, delineating the fund's strategic focus and expert area of investment. With their diverse industry interests and specialization in early-stage funding, Tectonic Capital offers substantial support for innovative and transformative startups looking to reshape their respective fields.
We partner with visionary entrepreneurs to build and scale innovative companies.
What we look for: We invest in category-defining businesses.








